Analyst Ratings and Price Targets (3/23/2021)
 

CompanyActionBrokerageCurrent PricePrice TargetRatingImpact on PriceActions
Alcoa logo
AA
Alcoa
Upgraded byDeutsche Bank Aktiengesellschaft$30.43
-2.3%
$36.00Hold ➝ BuyLow    
Advance Auto Parts logo
AAP
Advance Auto Parts
Target Raised byWells Fargo & Company$182.99
-1.6%
$165.00 ➝ $185.00Equal WeightLow    
Absolute Software logo
ABST
Absolute Software
Initiated byDesjardins$14.77
+3.9%
BuyLow    
Accenture logo
ACN
Accenture
Target Raised byMorgan Stanley$265.20
+0.5%
$297.00 ➝ $305.00OverweightLow    
Ares Commercial Real Estate logo
ACRE
Ares Commercial Real Estate
Target Raised byCredit Suisse Group$14.25
-0.3%
$13.00 ➝ $16.00OutperformLow    
AcuityAds logo
ACUIF
AcuityAds
Initiated byDesjardins$14.59
+2.2%
BuyLow    
ADCT
ADC Therapeutics
Target Lowered byMorgan Stanley$28.70
+2.2%
$56.00 ➝ $55.00OverweightLow    
Adient logo
ADNT
Adient
Reiterated byMorgan Stanley$40.89
-4.3%
$36.00 ➝ $38.00Equal Weight ➝ UnderweightN/A    
AEVA
Aeva Technologies
Initiated byCraig Hallum$14.23
-2.4%
$25.00BuyLow    
AEVA
Aeva Technologies
Initiated byRoth Capital$14.23
-2.4%
$30.00BuyLow    
Affirm logo
AFRM
Affirm
Target Lowered byDeutsche Bank Aktiengesellschaft$81.99
+5.6%
$120.00 ➝ $92.00HoldN/A    
Ashford logo
AINC
Ashford
Target Raised byB. Riley$10.73
-1.7%
$7.50 ➝ $10.00NeutralN/A    
Apartment Income REIT logo
AIRC
Apartment Income REIT
Upgraded byZelman & Associates$43.80
+1.7%
Sell ➝ HoldLow    
Akero Therapeutics logo
AKRO
Akero Therapeutics
Target Raised byChardan Capital$34.19
+7.2%
$79.00 ➝ $81.00BuyHigh    
Akero Therapeutics logo
AKRO
Akero Therapeutics
Target Lowered byMorgan Stanley$34.19
+7.2%
$70.00 ➝ $63.00OverweightHigh    
Akero Therapeutics logo
AKRO
Akero Therapeutics
Reiterated byHC Wainwright$34.19
+7.2%
$61.00 ➝ $68.00Positive ➝ BuyHigh    
Alexion Pharmaceuticals logo
ALXN
Alexion Pharmaceuticals
Downgraded bySVB Leerink$155.25
+2.8%
$196.00 ➝ $156.00Outperform ➝ Market PerformLow    
Alithya Group logo
ALYA
Alithya Group
Initiated byDesjardins$2.45
+3.7%
HoldLow    
Amalgamated Financial logo
AMAL
Amalgamated Financial
Downgraded byJPMorgan Chase & Co.$16.44
-6.4%
$18.50 ➝ $17.50Overweight ➝ NeutralLow    
Amphastar Pharmaceuticals logo
AMPH
Amphastar Pharmaceuticals
Target Lowered byWells Fargo & Company$18.49
+2.3%
$21.00 ➝ $20.00Equal WeightLow    
Applied Molecular Transport logo
AMTI
Applied Molecular Transport
Initiated byJMP Securities$53.98
-18.7%
$92.00OutperformLow    
American Woodmark logo
AMWD
American Woodmark
Initiated byWolfe Research$97.15
-3.2%
Peer PerformLow    
American Public Education logo
APEI
American Public Education
Initiated byWilliam Blair$37.07
-4.7%
OutperformMedium    
Agora logo
API
Agora
Initiated byMacquarie$59.16
+2.5%
$80.00OutperformLow    
Digital Turbine logo
APPS
Digital Turbine
Target Raised byRoth Capital$89.35
+9.3%
$100.00 ➝ $115.00BuyLow    
Aprea Therapeutics logo
APRE
Aprea Therapeutics
Target Lowered byRoyal Bank of Canada$5.59
-2.0%
$10.00 ➝ $8.00Sector PerformLow    
Evoqua Water Technologies logo
AQUA
Evoqua Water Technologies
Upgraded byBerenberg Bank$25.24
-1.8%
$25.00 ➝ $34.00Hold ➝ BuyHigh    
Apollo Commercial Real Estate Finance logo
ARI
Apollo Commercial Real Estate Finance
Target Raised byCredit Suisse Group$14.47
-1.1%
$13.00 ➝ $15.00NeutralLow    
ASLAN Pharmaceuticals logo
ASLN
ASLAN Pharmaceuticals
Target Raised byHC Wainwright$4.10
-0.5%
$5.00 ➝ $8.00BuyLow    
Assembly Biosciences logo
ASMB
Assembly Biosciences
Downgraded bySVB Leerink$4.69
-3.4%
$9.00 ➝ $8.00Outperform ➝ Market PerformHigh    
AvalonBay Communities logo
AVB
AvalonBay Communities
Upgraded byZelman & Associates$185.13
+1.3%
Sell ➝ HoldLow    
Mission Produce logo
AVO
Mission Produce
Downgraded byCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell$20.39
-2.1%
$16.00 ➝ $22.00Buy ➝ NeutralLow    
Avery Dennison logo
AVY
Avery Dennison
Reiterated byAtlantic Securities$180.43
+0.5%
Overweight ➝ NeutralLow    
AstraZeneca logo
AZN
AstraZeneca
Target Set byUBS GroupGBX 7,248
-1.3%
GBX 8,000BuyN/A    
AstraZeneca logo
AZN
AstraZeneca
Target Set byThe Goldman Sachs GroupGBX 7,248
-1.3%
GBX 6,800SellN/A    
AutoZone logo
AZO
AutoZone
Target Raised byWells Fargo & Company$1,341.22
+1.2%
$1,375.00 ➝ $1,500.00OverweightLow    
Azul logo
AZUL
Azul
Downgraded byMorgan Stanley$21.56
-6.4%
$15.20Equal Weight ➝ UnderweightHigh    
BridgeBio Pharma logo
BBIO
BridgeBio Pharma
Target Raised bySVB Leerink$69.11
+2.1%
$67.00 ➝ $75.00OutperformLow    
BBTV logo
BBTVF
BBTV
Initiated byDesjardins$8.26
-2.9%
BuyLow    
Bechtle logo
BC8
Bechtle
Target Set byDeutsche Bank Aktiengesellschaft€160.70
+1.4%
€170.00NeutralN/A    
Brighthouse Financial logo
BHF
Brighthouse Financial
Target Raised byCredit Suisse Group$44.42
-2.6%
$36.00 ➝ $42.00NeutralLow    
BioLife Solutions logo
BLFS
BioLife Solutions
Target Raised byKeyCorp$38.57
-0.5%
$40.00 ➝ $50.00OverweightHigh    
BioLife Solutions logo
BLFS
BioLife Solutions
Upgraded byBenchmark$38.57
-0.5%
$54.00Hold ➝ BuyHigh    
BioLife Solutions logo
BLFS
BioLife Solutions
Target Raised byMaxim Group$38.57
-0.5%
$40.00 ➝ $60.00BuyHigh    
BioLife Solutions logo
BLFS
BioLife Solutions
Target Raised byStephens$38.57
-0.5%
$50.00 ➝ $55.00Buy ➝ OverweightHigh    
BioMarin Pharmaceutical logo
BMRN
BioMarin Pharmaceutical
Reiterated byWedbush$78.52
+0.4%
$139.00OutperformLow    
BOX logo
BOX
BOX
Target Raised byKeyCorp$23.65
+4.6%
$22.00 ➝ $27.00OverweightHigh    
BP logo
BP
BP
Target Raised byRaymond James$25.35
-0.4%
$27.00 ➝ $29.00OutperformMedium    
Burlington Stores logo
BURL
Burlington Stores
Downgraded byBerenberg Bank$304.00
-1.0%
$304.00 ➝ $314.00Buy ➝ HoldLow    
Blackstone Mortgage Trust logo
BXMT
Blackstone Mortgage Trust
Target Raised byCredit Suisse Group$31.31
-0.9%
$28.00 ➝ $33.00NeutralLow    
Boyd Gaming logo
BYD
Boyd Gaming
Target Raised byDeutsche Bank Aktiengesellschaft$60.55
-3.4%
$65.00 ➝ $67.00BuyLow    
Bunzl logo
BZLFY
Bunzl
Upgraded byRoyal Bank of Canada$32.51
+1.6%
Underperform ➝ Sector PerformLow    
Cabaletta Bio logo
CABA
Cabaletta Bio
Target Raised byHC Wainwright$12.06
+6.2%
$20.00 ➝ $22.00BuyLow    
Conagra Brands logo
CAG
Conagra Brands
Target Raised byCredit Suisse Group$38.27
+1.1%
$33.00 ➝ $34.00UnderperformLow    
Check-Cap logo
CHEK
Check-Cap
Reiterated byDawson James$2.03
-5.9%
$2.00Buy ➝ NeutralN/A    
Coupa Software logo
COUP
Coupa Software
Target Lowered byWells Fargo & Company$258.04
+3.6%
$320.00 ➝ $305.00Equal WeightLow    
Coupa Software logo
COUP
Coupa Software
Target Lowered byRoyal Bank of Canada$258.04
+3.6%
$360.00 ➝ $340.00OutperformLow    
Coupa Software logo
COUP
Coupa Software
Target Lowered byOppenheimer$258.04
+3.6%
$380.00 ➝ $320.00OutperformLow    
Capri logo
CPRI
Capri
Target Raised byWells Fargo & Company$53.29
-3.6%
$60.00 ➝ $65.00OverweightLow    
CRAWA
Crawford United
Target Raised byB. Riley$30.15
flat
$24.00 ➝ $32.00BuyLow    
CrowdStrike logo
CRWD
CrowdStrike
Target Raised byOppenheimer$195.73
+0.6%
$190.00 ➝ $225.00OutperformLow    
CrowdStrike logo
CRWD
CrowdStrike
Target Raised byRoyal Bank of Canada$195.73
+0.6%
$220.00 ➝ $250.00OutperformLow    
CrowdStrike logo
CRWD
CrowdStrike
Target Raised byNeedham & Company LLC$195.73
+0.6%
$200.00 ➝ $275.00BuyLow    
CrowdStrike logo
CRWD
CrowdStrike
Target Raised byRobert W. Baird$195.73
+0.6%
$185.00 ➝ $235.00OutperformN/A    
CrowdStrike logo
CRWD
CrowdStrike
Target Raised byDA Davidson$195.73
+0.6%
$185.00 ➝ $250.00BuyN/A    
Credit Suisse Group logo
CS
Credit Suisse Group
Reiterated byKepler Capital Markets$13.15
+0.5%
Buy ➝ HoldMedium    
Credit Suisse Group logo
CS
Credit Suisse Group
Reiterated byDZ Bank$13.15
+0.5%
BuyLow    
Canadian Solar logo
CSIQ
Canadian Solar
Target Raised byRoth Capital$48.80
+6.9%
$50.00 ➝ $55.00BuyLow    
CSL logo
CSLLY
CSL
Upgraded byCredit Suisse Group$101.35
+2.0%
Neutral ➝ OutperformLow    
CytomX Therapeutics logo
CTMX
CytomX Therapeutics
Upgraded byJefferies Financial Group$8.52
+2.9%
Hold ➝ BuyHigh    
Citi Trends logo
CTRN
Citi Trends
Target Raised byCraig Hallum$89.66
-6.1%
$93.00 ➝ $125.00BuyN/A    
Converge Technology Solutions logo
CTSDF
Converge Technology Solutions
Initiated byDesjardins$4.59
+4.6%
BuyLow    
Cubic logo
CUB
Cubic
Reiterated byCanaccord Genuity$75.20
+7.3%
HoldLow    
CVS Health logo
CVS
CVS Health
Reiterated byGuggenheim$73.47
+0.4%
Buy ➝ NeutralLow    
Chevron logo
CVX
Chevron
Target Raised byEvercore ISI$102.54
-0.8%
$98.00 ➝ $130.00OutperformN/A    
Chevron logo
CVX
Chevron
Target Raised byRaymond James$102.54
-0.8%
$112.00 ➝ $122.00OutperformLow    
Daimler logo
DAI
Daimler
Reiterated byDZ Bank€74.16
+0.5%
BuyN/A    
JCDecaux logo
DEC
JCDecaux
Target Set byBerenberg Bank€20.60
+0.4%
€28.00BuyN/A    
Dollar General logo
DG
Dollar General
Target Lowered byMorgan Stanley$193.96
+3.2%
$245.00 ➝ $225.00OverweightLow    
Discovery logo
DISCA
Discovery
Downgraded byUBS Group$74.65
-3.5%
$24.00 ➝ $46.00Neutral ➝ SellLow    
Darden Restaurants logo
DRI
Darden Restaurants
Target Raised byRoyal Bank of Canada$136.74
-2.2%
$138.00 ➝ $151.00OutperformLow    
DRKOF
Martello Technologies Group
Initiated byDesjardins$0.13
flat
BuyLow    
Viant Technology logo
DSP
Viant Technology
Target Raised byCanaccord Genuity$59.74
+12.5%
$52.00 ➝ $65.00BuyHigh    
Viant Technology logo
DSP
Viant Technology
Target Raised byNeedham & Company LLC$59.74
+12.5%
$50.00 ➝ $62.00BuyHigh    
Deutsche Telekom logo
DTE
Deutsche Telekom
Target Set byCredit Suisse Group€16.45
-0.1%
€20.00BuyN/A    
Devon Energy logo
DVN
Devon Energy
Initiated byThe Goldman Sachs Group$22.33
-1.7%
$30.75BuyLow    
Euronet Worldwide logo
EEFT
Euronet Worldwide
Target Raised byDA Davidson$144.34
-2.4%
$166.00 ➝ $180.00BuyN/A    
Euronet Worldwide logo
EEFT
Euronet Worldwide
Target Raised byWells Fargo & Company$144.34
-2.4%
$165.00 ➝ $180.00OverweightLow    
eHealth logo
EHTH
eHealth
Target Raised byEvercore ISI$68.09
+4.5%
$60.00 ➝ $80.00Positive ➝ OutperformHigh    
eHealth logo
EHTH
eHealth
Target Raised byCredit Suisse Group$68.09
+4.5%
$63.00 ➝ $78.00OutperformHigh    
Enthusiast Gaming logo
ENGMF
Enthusiast Gaming
Target Raised byB. Riley$7.55
+2.5%
$10.00 ➝ $11.50BuyHigh    
Equity Residential logo
EQR
Equity Residential
Upgraded byZelman & Associates$72.03
+0.8%
Sell ➝ HoldLow    
Embraer logo
ERJ
Embraer
Reiterated byJPMorgan Chase & Co.$9.76
-9.4%
$9.50 ➝ $13.50OverweightHigh    
89bio logo
ETNB
89bio
Target Raised bySVB Leerink$26.73
+6.1%
$56.00 ➝ $62.00OutperformHigh    
Eton Pharmaceuticals logo
ETON
Eton Pharmaceuticals
Target Lowered byHC Wainwright$7.65
-4.4%
$15.00 ➝ $14.00BuyLow    
ETWO
E2open Parent
Initiated byUBS Group$10.63
+0.5%
$12.00NeutralLow    
CTS Eventim AG & Co. KGaA logo
EVD
CTS Eventim AG & Co. KGaA
Target Set byBaader Bank€52.30
-3.3%
€30.00SellN/A    
Forte Biosciences logo
FBRX
Forte Biosciences
Target Lowered byChardan Capital$28.46
+2.0%
$115.00 ➝ $105.00BuyN/A    
First Financial Northwest logo
FFNW
First Financial Northwest
Upgraded byDA Davidson$14.46
-3.0%
Neutral ➝ BuyLow    
Foghorn Therapeutics logo
FHTX
Foghorn Therapeutics
Target Lowered byMorgan Stanley$16.87
+4.4%
$24.00 ➝ $23.00OverweightLow    
Fluent logo
FLNT
Fluent
Reiterated byBarrington Research$4.65
-0.9%
Outperform ➝ Market PerformLow    
Freddie Mac logo
FMCC
Freddie Mac
Upgraded byOdeon Capital Group$1.84
-0.5%
$0.50 ➝ $2.00Sell ➝ HoldLow    
Funko logo
FNKO
Funko
Upgraded byBMO Capital Markets$16.50
-6.5%
$5.00 ➝ $16.00Underperform ➝ Market PerformLow    
Federal National Mortgage Association logo
FNMA
Federal National Mortgage Association
Upgraded byOdeon Capital Group$1.91
+0.5%
$0.50 ➝ $2.00Sell ➝ HoldLow    
FUTU
Futu
Target Lowered byCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell$123.83
-6.4%
$246.50 ➝ $230.30BuyLow    
GFL Environmental logo
GFL
GFL Environmental
Target Raised byRaymond James$33.46
+1.0%
$33.00 ➝ $35.00OutperformHigh    
CGI logo
GIB
CGI
Initiated byDesjardins$82.55
+1.1%
BuyLow    
General Mills logo
GIS
General Mills
Target Raised byCredit Suisse Group$61.45
+2.2%
$62.00 ➝ $66.00OutperformLow    
GenMark Diagnostics logo
GNMK
GenMark Diagnostics
Reiterated byCowen$24.00
-0.2%
$23.00 ➝ $24.05Outperform ➝ Market PerformLow    
GenMark Diagnostics logo
GNMK
GenMark Diagnostics
Reiterated byBTIG Research$24.00
-0.2%
Buy ➝ NeutralLow    
Gol Linhas Aéreas Inteligentes logo
GOL
Gol Linhas Aéreas Inteligentes
Downgraded byMorgan Stanley$7.56
-3.3%
$5.90Equal Weight ➝ UnderweightHigh    
Group 1 Automotive logo
GPI
Group 1 Automotive
Target Raised byStephens$157.63
-4.2%
$163.00 ➝ $180.00OverweightLow    
Granite Point Mortgage Trust logo
GPMT
Granite Point Mortgage Trust
Target Raised byCredit Suisse Group$12.48
-1.8%
$10.50 ➝ $12.00NeutralLow    
Grifols logo
GRFS
Grifols
Upgraded byCredit Suisse Group$16.00
-0.6%
Neutral ➝ OutperformMedium    
GlaxoSmithKline logo
GSK
GlaxoSmithKline
Downgraded bySVB Leerink$36.67
+0.1%
Outperform ➝ Market PerformLow    
GTBP
GT Biopharma
Initiated byRoth Capital$6.69
+1.5%
$25.00BuyLow    
Helen of Troy logo
HELE
Helen of Troy
Reiterated byDA Davidson$213.37
+1.9%
$260.00 ➝ $247.00Buy ➝ NeutralLow    
HelloFresh logo
HFG
HelloFresh
Target Set byCredit Suisse Group€66.10
+4.2%
€81.00BuyN/A    
Hapag-Lloyd Aktiengesellschaft logo
HLAG
Hapag-Lloyd Aktiengesellschaft
Target Set byKepler Capital Markets€141.20
-2.5%
€135.00NeutralN/A    
HELLA GmbH & Co. KGaA logo
HLE
HELLA GmbH & Co. KGaA
Target Set byThe Goldman Sachs Group€49.06
-2.2%
€66.00BuyN/A    
Hammerson logo
HMSNF
Hammerson
Downgraded byPeel Hunt$0.44
-18.0%
Hold ➝ SellLow    
Hapag-Lloyd Aktiengesellschaft logo
HPGLY
Hapag-Lloyd Aktiengesellschaft
Downgraded byJPMorgan Chase & Co.$81.50
flat
Neutral ➝ UnderweightLow    
HealthEquity logo
HQY
HealthEquity
Target Raised byDeutsche Bank Aktiengesellschaft$70.91
-1.1%
$88.00 ➝ $92.00BuyN/A    
Herc logo
HRI
Herc
Target Raised byKeyCorp$98.23
-1.4%
$98.00 ➝ $112.00OverweightLow    
The Hershey logo
HSY
The Hershey
Upgraded byPiper Sandler$156.38
+1.1%
Neutral ➝ OverweightLow    
Hancock Whitney logo
HWC
Hancock Whitney
Target Raised byRaymond James$42.80
-4.0%
$46.00 ➝ $51.00OutperformLow    
Horizon Therapeutics Public logo
HZNP
Horizon Therapeutics Public
Target Raised byStifel Nicolaus$90.38
+0.9%
$110.00 ➝ $125.00BuyN/A    
IAC/InterActiveCorp logo
IAC
IAC/InterActiveCorp
Target Raised byKeyCorp$248.07
+2.4%
$265.00 ➝ $276.00OverweightHigh    
iCAD logo
ICAD
iCAD
Initiated byBTIG Research$19.35
+3.2%
$25.00BuyLow    
ID
Magal Security Systems
Initiated byDA Davidson$6.44
-2.2%
$12.00BuyLow    
Immatics logo
IMTX
Immatics
Target Raised bySVB Leerink$13.68
-3.7%
$17.00 ➝ $26.00OutperformN/A    
Infinity Pharmaceuticals logo
INFI
Infinity Pharmaceuticals
Target Lowered byB. Riley$3.64
flat
$8.00 ➝ $7.00BuyLow    
Infinity Pharmaceuticals logo
INFI
Infinity Pharmaceuticals
Target Raised byWells Fargo & Company$3.64
flat
$2.00 ➝ $4.00Equal WeightLow    
Inovio Pharmaceuticals logo
INO
Inovio Pharmaceuticals
Initiated byBank of America$10.32
+2.0%
$13.00NeutralLow    
Ionis Pharmaceuticals logo
IONS
Ionis Pharmaceuticals
Target Lowered byRoyal Bank of Canada$55.64
+2.6%
$76.00 ➝ $65.00Positive ➝ OutperformHigh    
Ionis Pharmaceuticals logo
IONS
Ionis Pharmaceuticals
Target Lowered byBarclays$55.64
+2.6%
$52.00 ➝ $47.00Equal WeightHigh    
Ionis Pharmaceuticals logo
IONS
Ionis Pharmaceuticals
Target Lowered bySVB Leerink$55.64
+2.6%
$50.00 ➝ $36.00Market PerformHigh    
Ionis Pharmaceuticals logo
IONS
Ionis Pharmaceuticals
Target Lowered byMorgan Stanley$55.64
+2.6%
$50.00 ➝ $43.00UnderweightHigh    
Ionis Pharmaceuticals logo
IONS
Ionis Pharmaceuticals
Target Lowered byNeedham & Company LLC$55.64
+2.6%
$95.00 ➝ $86.00BuyHigh    
JCDecaux logo
JCDXF
JCDecaux
Upgraded byBerenberg Bank$24.58
flat
Hold ➝ BuyLow    
Johnson Matthey logo
JMPLY
Johnson Matthey
Initiated byJefferies Financial Group$82.25
-1.1%
BuyLow    
Klöckner & Co SE logo
KCO
Klöckner & Co SE
Target Set byKepler Capital Markets€9.85
+2.2%
€12.00BuyN/A    
The Kraft Heinz logo
KHC
The Kraft Heinz
Target Raised byCredit Suisse Group$39.55
+1.0%
$32.00 ➝ $35.00UnderperformLow    
Kymera Therapeutics logo
KYMR
Kymera Therapeutics
Target Lowered byMorgan Stanley$47.02
+5.0%
$74.00 ➝ $69.00Equal WeightLow    
LCY
Landcadia Holdings III
Initiated byBenchmark$10.38
-2.3%
$16.00BuyLow    
Lear logo
LEA
Lear
Reiterated byWolfe Research$179.09
-2.4%
Outperform ➝ Peer PerformLow    
Leaf Group logo
LEAF
Leaf Group
Initiated byBTIG Research$7.42
-4.3%
$9.50BuyHigh    
Legacy Housing logo
LEGH
Legacy Housing
Upgraded byB. Riley$17.79
-1.7%
$20.00Neutral ➝ BuyHigh    
Leoni logo
LEO
Leoni
Target Set byIndependent Research€11.61
-3.5%
€9.10SellN/A    
LOTZ
CarLotz
Initiated byBarrington Research$7.78
-5.1%
$22.00OutperformHigh    
Lululemon Athletica logo
LULU
Lululemon Athletica
Target Lowered byMorgan Stanley$313.60
+1.6%
$400.00 ➝ $386.00Equal WeightLow    
Southwest Airlines logo
LUV
Southwest Airlines
Upgraded byArgus$59.46
-2.7%
$68.00Hold ➝ BuyLow    
Lyft logo
LYFT
Lyft
Target Raised byWedbush$64.16
-3.7%
$72.00 ➝ $85.00OutperformLow    
Masco logo
MAS
Masco
Initiated byWolfe Research$57.79
+0.8%
Peer PerformLow    
Maxar Technologies logo
MAXR
Maxar Technologies
Initiated byTruist Securities$38.92
+4.0%
$59.00BuyLow    
McDonald's logo
MCD
McDonald's
Upgraded byDeutsche Bank Aktiengesellschaft$225.07
+1.2%
$244.00Hold ➝ BuyLow    
Microchip Technology logo
MCHP
Microchip Technology
Upgraded byLongbow Research$154.86
+3.1%
$188.00Neutral ➝ BuyHigh    
MongoDB logo
MDB
MongoDB
Initiated byUBS Group$309.77
+2.3%
$325.00NeutralLow    
MDU Resources Group logo
MDU
MDU Resources Group
Initiated byBank of America$29.82
-3.0%
$36.00BuyLow    
mdf commerce logo
MECVF
mdf commerce
Initiated byDesjardins$10.31
flat
BuyLow    
Medpace logo
MEDP
Medpace
Target Raised byCredit Suisse Group$164.45
-1.3%
$178.00 ➝ $181.00OutperformLow    
Mercer International logo
MERC
Mercer International
Reiterated byCredit Suisse Group$14.44
+0.4%
$16.00 ➝ $18.00Outperform ➝ NeutralLow    
Mohawk Industries logo
MHK
Mohawk Industries
Initiated byWolfe Research$183.15
-0.3%
Peer PerformLow    
McCormick & Company, Incorporated logo
MKC
McCormick & Company, Incorporated
Reiterated byArgus$87.85
+1.5%
Buy ➝ HoldLow    
3M logo
MMM
3M
Target Raised byCredit Suisse Group$189.47
+0.4%
$197.00 ➝ $202.00OutperformLow    
MedMen Enterprises logo
MMNFF
MedMen Enterprises
Reiterated byCantor Fitzgerald$0.36
-5.5%
Neutral ➝ UnderweightLow    
Mondi logo
MONDY
Mondi
Initiated byBerenberg Bank$51.82
-0.2%
HoldLow    
MorphoSys logo
MOR
MorphoSys
Reiterated bySVB Leerink$23.23
+0.3%
Outperform ➝ Market PerformLow    
MPSYF
MorphoSys
Downgraded bySVB Leerink$99.95
+1.2%
Outperform ➝ Market PerformLow    
Monolithic Power Systems logo
MPWR
Monolithic Power Systems
Reiterated byNeedham & Company LLC$348.24
+1.5%
$415.00BuyLow    
Merus logo
MRUS
Merus
Target Raised byHC Wainwright$23.17
+0.9%
$23.00 ➝ $30.00BuyLow    
Merus logo
MRUS
Merus
Target Raised byRoyal Bank of Canada$23.17
+0.9%
$15.00 ➝ $21.00Sector PerformLow    
Micron Technology logo
MU
Micron Technology
Target Raised byCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell$91.28
+0.8%
$116.00 ➝ $130.00BuyLow    
Nemetschek logo
NEM
Nemetschek
Target Set byThe Goldman Sachs Group€54.65
+2.4%
€56.00NeutralN/A    
Nemetschek logo
NEM
Nemetschek
Target Set byWarburg Research€54.65
+2.4%
€64.00BuyN/A    
Nemetschek logo
NEM
Nemetschek
Target Set byBaader Bank€54.65
+2.4%
€54.00SellN/A    
Netflix logo
NFLX
Netflix
Upgraded byArgus$523.11
+2.1%
$650.00Hold ➝ BuyLow    
NIKE logo
NKE
NIKE
Target Raised byCowen$138.27
+0.6%
$170.00 ➝ $173.00OutperformN/A    
Noah logo
NOAH
Noah
Upgraded byNomura Instinet$45.89
-2.3%
Neutral ➝ BuyLow    
NRG Energy logo
NRG
NRG Energy
Reiterated byWolfe Research$35.78
-3.5%
$47.00Outperform ➝ Peer PerformLow    
NorthWestern logo
NWE
NorthWestern
Upgraded byBank of America$62.73
-1.4%
$62.00Underperform ➝ NeutralHigh    
NatWest Group logo
NWG
NatWest Group
Upgraded byThe Goldman Sachs Group$5.37
+1.5%
Buy ➝ Conviction-BuyN/A    
Owens Corning logo
OC
Owens Corning
Initiated byWolfe Research$89.82
-1.2%
Peer PerformLow    
OncoCyte logo
OCX
OncoCyte
Reiterated byNeedham & Company LLC$4.69
-2.3%
$8.00BuyN/A    
Olin logo
OLN
Olin
Target Raised byWells Fargo & Company$37.77
-5.4%
$39.00 ➝ $50.00OverweightLow    
Olin logo
OLN
Olin
Target Raised byKeyCorp$37.77
-5.4%
$34.00 ➝ $48.00OverweightLow    
ORGO
Organogenesis
Target Raised bySVB Leerink$21.06
+11.3%
$19.00 ➝ $22.00OutperformMedium    
O'Reilly Automotive logo
ORLY
O'Reilly Automotive
Target Raised byWells Fargo & Company$490.84
+0.6%
$525.00 ➝ $535.00OverweightLow    
Old Second Bancorp logo
OSBC
Old Second Bancorp
Target Raised byRaymond James$13.54
-0.8%
$13.00 ➝ $16.00Strong-BuyLow    
OSMT
Osmotica Pharmaceuticals
Target Lowered byRoyal Bank of Canada$3.79
-2.1%
$12.00 ➝ $8.00OutperformLow    
Oxford Square Capital logo
OXSQ
Oxford Square Capital
Upgraded byLADENBURG THALM/SH SH$4.15
+1.0%
Neutral ➝ BuyHigh    
PAE logo
PAE
PAE
Reiterated byDeutsche Bank Aktiengesellschaft$8.54
-1.4%
$10.50Buy ➝ HoldHigh    
PotlatchDeltic logo
PCH
PotlatchDeltic
Reiterated byDA Davidson$51.07
+0.1%
Buy ➝ NeutralLow    
Pinduoduo logo
PDD
Pinduoduo
Reiterated byMacquarie$137.15
-3.4%
$171.00 ➝ $157.00Outperform ➝ NeutralN/A    
Pfizer logo
PFE
Pfizer
Target Set byBerenberg Bank$36.00
+1.3%
$38.00NeutralLow    
Parker-Hannifin logo
PH
Parker-Hannifin
Target Raised byMorgan Stanley$310.98
0.0%
$317.00 ➝ $350.00OverweightHigh    
Plug Power logo
PLUG
Plug Power
Target Lowered byCraig Hallum$38.91
+1.6%
$88.00 ➝ $49.00BuyN/A    
Plug Power logo
PLUG
Plug Power
Reiterated byTruist Securities$38.91
+1.6%
$65.00 ➝ $42.00Buy ➝ HoldLow    
Pinnacle Financial Partners logo
PNFP
Pinnacle Financial Partners
Target Raised byStephens$89.38
-2.9%
$80.00 ➝ $96.00OverweightLow    
POCEF
Photon Control
Initiated byDesjardins$2.05
+2.4%
BuyLow    
PRLD
Prelude Therapeutics
Target Raised byMorgan Stanley$58.39
+6.4%
$47.00 ➝ $60.00Equal WeightLow    
Phillips 66 logo
PSX
Phillips 66
Target Raised byCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell$80.58
-2.1%
$81.00 ➝ $99.00BuyMedium    
Phillips 66 logo
PSX
Phillips 66
Target Raised byRaymond James$80.58
-2.1%
$80.00 ➝ $100.00OutperformMedium    
Prudential logo
PUK
Prudential
Upgraded byHSBC$42.22
-0.3%
Hold ➝ BuyLow    
Pioneer Natural Resources logo
PXD
Pioneer Natural Resources
Target Raised byKeyCorp$158.66
-3.0%
$168.00 ➝ $178.00OverweightN/A    
Restaurant Brands International logo
QSR
Restaurant Brands International
Target Raised byWells Fargo & Company$64.17
-0.1%
$75.00 ➝ $80.00Positive ➝ OverweightLow    
QUISF
Quisitive Technology Solutions
Initiated byDesjardins$1.26
+7.9%
BuyN/A    
QUISF
Quisitive Technology Solutions
Reiterated byCanaccord Genuity$1.26
+7.9%
BuyN/A    
RADA Electronic Industries logo
RADA
RADA Electronic Industries
Initiated byRobert W. Baird$12.17
-2.9%
$17.00OutperformLow    
Rémy Cointreau logo
REMYY
Rémy Cointreau
Upgraded byJPMorgan Chase & Co.$19.22
+1.7%
Underweight ➝ NeutralLow    
Resideo Technologies logo
REZI
Resideo Technologies
Initiated byMorgan Stanley$28.99
-2.5%
$33.00Equal WeightLow    
Roche logo
RHHVF
Roche
Reiterated byJPMorgan Chase & Co.$335.20
+2.1%
HoldLow    
Roche logo
RHHVF
Roche
Reiterated byUBS Group$335.20
+2.1%
HoldLow    
Ra Medical Systems logo
RMED
Ra Medical Systems
Reiterated byMaxim Group$6.16
-1.0%
Buy ➝ HoldLow    
Retail Opportunity Investments logo
ROIC
Retail Opportunity Investments
Target Raised byWells Fargo & Company$16.18
-1.0%
$14.00 ➝ $15.00UnderweightLow    
Rockwell Automation logo
ROK
Rockwell Automation
Target Raised byMorgan Stanley$261.87
+1.4%
$291.00 ➝ $300.00OverweightLow    
Roper Technologies logo
ROP
Roper Technologies
Upgraded byOppenheimer$401.29
+1.6%
$460.00Market Perform ➝ OutperformLow    
RPT Realty logo
RPT
RPT Realty
Target Raised byKeyCorp$11.82
-1.3%
$11.00 ➝ $13.00OverweightLow    
Shop Apotheke Europe logo
SAE
Shop Apotheke Europe
Target Set byKepler Capital Markets€181.00
-2.3%
€108.00SellN/A    
Shop Apotheke Europe logo
SAE
Shop Apotheke Europe
Target Set byHauck & Aufhaeuser€181.00
-2.3%
€205.00NeutralN/A    
Shop Apotheke Europe logo
SAEYY
Shop Apotheke Europe
Initiated byMorgan Stanley$21.35
flat
OverweightLow    
Saipem logo
SAPMY
Saipem
Downgraded byHSBC$5.55
flat
Buy ➝ HoldLow    
Cassava Sciences logo
SAVA
Cassava Sciences
Initiated byJonestrading$55.81
-3.5%
BuyLow    
Starbucks logo
SBUX
Starbucks
Target Raised byTelsey Advisory Group$107.57
+1.1%
$108.00 ➝ $120.00Market PerformLow    
SharpSpring logo
SHSP
SharpSpring
Reiterated byCraig Hallum$17.14
-1.6%
Buy ➝ HoldLow    
The Sherwin-Williams logo
SHW
The Sherwin-Williams
Initiated byWolfe Research$720.24
+1.9%
Peer PerformLow    
The J. M. Smucker logo
SJM
The J. M. Smucker
Target Raised byCredit Suisse Group$127.25
+0.7%
$120.00 ➝ $123.00NeutralLow    
SM Energy logo
SM
SM Energy
Target Raised byKeyCorp$16.95
-8.3%
$19.00 ➝ $20.00OverweightN/A    
Smartsheet logo
SMAR
Smartsheet
Target Lowered byBMO Capital Markets$66.65
+6.1%
$86.00 ➝ $83.00OutperformN/A    
Smartsheet logo
SMAR
Smartsheet
Target Raised byKeyCorp$66.65
+6.1%
$82.00 ➝ $84.00OverweightLow    
Smartsheet logo
SMAR
Smartsheet
Upgraded byJPMorgan Chase & Co.$66.65
+6.1%
$83.00Neutral ➝ OverweightLow    
Snowflake logo
SNOW
Snowflake
Initiated byUBS Group$220.75
0.0%
$275.00BuyLow    
SeaSpine logo
SPNE
SeaSpine
Reiterated byCanaccord Genuity$18.34
-4.2%
$25.00BuyLow    
Spruce Biosciences logo
SPRB
Spruce Biosciences
Target Lowered byCredit Suisse Group$17.97
+2.9%
$28.00 ➝ $26.00OutperformLow    
Extended Stay America logo
STAY
Extended Stay America
Reiterated byStifel Nicolaus$19.73
+1.8%
$17.50 ➝ $19.50Buy ➝ HoldLow    
STORE Capital logo
STOR
STORE Capital
Target Raised byWells Fargo & Company$32.74
+0.6%
$36.00 ➝ $38.00OverweightLow    
Starwood Property Trust logo
STWD
Starwood Property Trust
Target Raised byCredit Suisse Group$24.97
+0.4%
$21.50 ➝ $26.00OutperformLow    
Seagate Technology logo
STX
Seagate Technology
Upgraded byCowen$75.94
+1.7%
$66.00 ➝ $95.00Market Perform ➝ OutperformLow    
SY
So-Young International
Target Lowered byCanaccord Genuity$10.01
-20.2%
$16.00 ➝ $14.00BuyMedium    
SY
So-Young International
Target Lowered byNeedham & Company LLC$10.01
-20.2%
$16.00 ➝ $14.00BuyLow    
Salzgitter logo
SZG
Salzgitter
Target Set byKepler Capital Markets€23.12
-0.7%
€28.00NeutralN/A    
Translate Bio logo
TBIO
Translate Bio
Downgraded bySVB Leerink$16.37
-0.5%
$21.00 ➝ $18.00Outperform ➝ Market PerformLow    
Teladoc Health logo
TDOC
Teladoc Health
Target Lowered byDeutsche Bank Aktiengesellschaft$197.28
+3.2%
$263.00 ➝ $226.00BuyN/A    
Thermon Group logo
THR
Thermon Group
Target Raised byRosenblatt Securities$19.40
-3.5%
$23.00 ➝ $26.00BuyLow    
The TJX Companies logo
TJX
The TJX Companies
Target Lowered byWells Fargo & Company$66.50
-0.2%
$84.00 ➝ $75.00OverweightLow    
thyssenkrupp logo
TKA
thyssenkrupp
Target Set byKepler Capital Markets€10.62
-2.5%
€13.00NeutralN/A    
Tencent Music Entertainment Group logo
TME
Tencent Music Entertainment Group
Downgraded byChina Renaissance Securities$30.87
+1.5%
$18.00 ➝ $29.00Buy ➝ HoldHigh    
Tempur Sealy International logo
TPX
Tempur Sealy International
Target Raised byKeyCorp$38.88
-1.5%
$37.00 ➝ $41.00OverweightLow    
Thomson Reuters logo
TRI
Thomson Reuters
Target Lowered byMorgan Stanley$87.91
+0.6%
$98.00 ➝ $92.00Equal WeightLow    
Takkt logo
TTK
Takkt
Target Set byBerenberg Bank€12.62
+1.3%
€17.00BuyN/A    
Texas Instruments logo
TXN
Texas Instruments
Upgraded byLongbow Research$180.10
+2.3%
$220.00Neutral ➝ BuyHigh    
Unilever logo
ULVR
Unilever
Target Set byDeutsche Bank AktiengesellschaftGBX 4,051
+0.7%
GBX 5,500BuyN/A    
Unilever logo
ULVR
Unilever
Target Set byUBS GroupGBX 4,051
+0.7%
GBX 3,700SellN/A    
Americas Silver logo
USAS
Americas Silver
Target Lowered byHC Wainwright$2.46
-4.5%
$5.25 ➝ $5.00BuyN/A    
Americas Silver logo
USAS
Americas Silver
Reiterated byAlliance Global Partners$2.46
-4.5%
$5.25 ➝ $4.50BuyN/A    
Universal Technical Institute logo
UTI
Universal Technical Institute
Reiterated byCanaccord Genuity$5.74
-2.1%
$11.00BuyLow    
Utz Brands logo
UTZ
Utz Brands
Initiated byTruist$25.94
-2.4%
HoldLow    
Utz Brands logo
UTZ
Utz Brands
Initiated byTruist Securities$25.94
-2.4%
$25.00HoldLow    
Energy Fuels logo
UUUU
Energy Fuels
Reiterated byHC Wainwright$6.18
-5.5%
$4.50 ➝ $7.25BuyN/A    
Valero Energy logo
VLO
Valero Energy
Target Raised byRaymond James$72.28
-2.0%
$69.00 ➝ $96.00OutperformMedium    
Volkswagen logo
VOW3
Volkswagen
Target Set byKepler Capital Markets€237.60
+6.8%
€270.00BuyN/A    
Vistra logo
VST
Vistra
Reiterated byGuggenheim$16.70
-3.6%
Buy ➝ NeutralN/A    
Vistra logo
VST
Vistra
Reiterated byWolfe Research$16.70
-3.6%
$24.00 ➝ $20.00Outperform ➝ Peer PerformLow    
Wacker Chemie logo
WCH
Wacker Chemie
Target Set byKepler Capital Markets€111.95
+1.7%
€125.00NeutralN/A    
Workday logo
WDAY
Workday
Target Raised byCanaccord Genuity$257.27
+2.3%
$265.00 ➝ $300.00BuyN/A    
WisdomTree Investments logo
WETF
WisdomTree Investments
Reiterated byNorthcoast Research$6.31
-0.6%
Buy ➝ NeutralLow    
Westport Fuel Systems logo
WPRT
Westport Fuel Systems
Target Raised byHC Wainwright$8.64
-2.4%
$5.00 ➝ $16.00BuyLow    
Williams-Sonoma logo
WSM
Williams-Sonoma
Target Raised byWells Fargo & Company$180.00
+2.9%
$135.00 ➝ $155.00Equal WeightN/A    
Acceleron Pharma logo
XLRN
Acceleron Pharma
Downgraded bySVB Leerink$143.64
+3.9%
$148.00Outperform ➝ Market PerformLow    
Qualtrics International logo
XM
Qualtrics International
Initiated byHSBC$34.82
+3.0%
$40.00HoldLow    
Zebra Technologies logo
ZBRA
Zebra Technologies
Upgraded byNorthcoast Research$463.77
+0.8%
$560.00Neutral ➝ BuyLow    
Zur Rose Group logo
ZRSEF
Zur Rose Group
Initiated byMorgan Stanley$370.00
-5.4%
OverweightLow    
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.

Always Get the Latest Analyst Ratings and Price Targets: Stay ahead of the market with MarketBeat.com's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register.

This page was last refreshed on Tuesday at 09:26 AM ET.

Terms like “Buy”, “Sell”, and “Hold” are synonymous with financial analysts’ reports, yet very few people have a clear understanding of what they are and the best way to use them for value generation in the stock market.  The terms are usually the result of thorough investigations carried out by brokerage firms and analysts as they look to make it easy for investors to make informed decisions about investments.

Market ratings are a multi-level recommendation system based on facts and the opinion of a financial analyst. The fact that there is a multitude of firms issuing differing ratings and a lack of a standard terminology explains why it is essential to understand what the ratings are all about and their meaning before using them for investment decisions.

What Are Stock Ratings

A stock rating refers to an evaluation of a stock’s expected performance in a given time period.  The rating is usually accompanied by a target price that analysts or brokerage firm issue with the aim of helping clients understand what is the fair price of a stock compared to its market value.

A stock rating will often come with a price target that shows what analysts believe is the fair value for the stock. Whenever the price target exceeds the market value, then it implies analysts believe the stock is a buy.  If the market price for the stock exceeds the target price, analysts or brokerage firms would say that the stock is a sell.

Understanding Analysts Stock Ratings

Analysts' ratings range from a simple buy, sell or hold to an equal-weight, overweight or outperform. Many brokerage firms rate a stock on a scale of one to five stars, with five being the highest rating. The ratings are assigned depending on the kind of earnings the company has reported or what it is expected to report as well as on valuations and stock price.

Corporate governance, as well as the scalability of a company’s business, are also taken into consideration when rating stocks. Analysts also pay close attention to a company’s competitive edge in the industry, as it is known to affect performance most of the time.

Market conditions also play into how stocks are rated. For example, in a bull market, analysts are usually swayed to keep favorable ratings for a long time while upgrading share price target. Conversely, during a bear market, analysts may resort to downgrading stock ratings.

While ratings may seem straightforward to an investing newcomer, in reality, a rating from one brokerage firm may mean an entirely different thing in another firm. For example, an outperform rating issued by one firm may mean a buy for another firm, while a sell may mean under­perform.

When it comes to integrating analysts' ratings, it is important first to review a firm’s rating scale to get a full understanding of what it is all about and what it means.  For example, a stock with the potential of delivering a 15% upside in price may be rated as a buy while one with a 5% upside rated as a hold.

Types of Stock Ratings

Buy Stock Rating: A buy rating indicates that a stock is worth buying at a given market price as it is destined to rise. Some firms use ‘strong buy’ to indicate how confident they are that a stock will climb higher given the strong fundamentals backing a move on the upside.

Sell Stock Rating: Sell recommendations are normally issued whenever analysts believe a stock is overvalued or fundamentals do not add up to support any movements on the upside. Some firms use ‘strong sell' to indicate that it is time to liquidate the security.

Hold Stock Rating: A security hit with a hold rating is most of the time expected to perform at the same pace as other stocks in the sector.

Underperform:  Analysts issue an underperform rating whenever they feel a stock is likely to fair worse than the overall market.  The rating is most of the time expressed as a moderate sell, warning investors who are long that a stock is losing upside momentum.

Outperform Stock Rating:  An outperform rating indicates that a stock is likely to perform much better than the market when it comes to returns. Also known as moderate buy or overweight, the rating hints at an uptrend gaining momentum.

It is important to read each rating definition to have a clear understanding of what it means given that ratings from different firms do differ a great deal.  Some ratings do offer specific recommendations while others are usually general in nature. One firm may say it expects a stock to appreciate by between 10 and 20% while another firm may say it expects a stock to appreciate over the next 12 months.

Brokerage Firm

Buy

Strong Buy

Out­perform

Hold

Sell

Under­perform

BB&T Capital Markets

 

Esti­mated return of greater than or equal to 25%

 

Esti­mated Total Return  greater than or equal to 0%

 

Esti­mated Total Return of Less than 0%

Blay­lock Partners

Stock Expected to out­perform market indexes by 20%

 

 

Expects stock to track recog­nized market indexes

Expects stock  to under­perform the overall market by 20%

 

Barring­ton Research

 

Expected to out­perform the market over the next 6 months

Expected to out­perform the market over the next 12 months

 

Expected to significantly under­perform the market as a result of deterior­ating fundamentals

 

Brean Murray & Co

Stock expected to out­perform the market over the next 12 months with moderate risks to funda­mentals

Stock expected to out­perform the market over the next 12 months it minimal risks to funda­mentals

 

Expected to perform in line with the market over the next 6-12 months

Exacted to under­perform the market over the next 6-12 months with high risk to funda­mentals

 

Deutsche Bank  Securities

Stock poised to outperform the market by 10% or more over the next 12 months

Repre­sents firm best picks with a high degree of confi­dence. Stock expected to out­perform the market

 

 

 

Stock expected to under­perform the market by 10% over the next 12 months

Jefferies & Co

A stock is expected to appre­ciate by 20% or more. The total return should exceed the industry average

 

 

Stock expected to change plus or minus 10%. The total return should be  in line with the industry's average

Stock expected to decrease by more than 10%

 

 

Why Stock Ratings Matter

While investors have a love-hate relationship with stock analysts’ ratings, they still matter a lot, as they convey how professionals feel about a given security. They will always stand out in part because they are the result of reasoned and objective analysis of experienced professionals.

Analysts and brokerage firms spend a good amount of time and effort to analyze companies in a bid to come up with accurate stock ratings that investors can rely on for making informed investment decisions. Investors should always remember that analysts do their best with stock ratings to find good investments for their clients in order to secure their reputation in the industry as well as the commissions they earn for such pieces of information.

Legitimate ratings will always be valuable pieces of information that investors can rely on to beat the market and in the process generate substantial returns. However, while it is essential to always be on the lookout for analysts’ ratings, it does not mean that investors should always adjust their position based on such reports.

Such reports should only be used to complement individual research work prior to making an investment decision.  Stock analysts’ reports should thus be used to find a company with a durable competitive advantage.

Stock ratings are a great place to start when selecting stocks

Stock analysts' rating pages are a great place to start when looking for potential stocks to invest in. Such recommendations go a long way in providing insight on stocks that are performing and likely to perform even better going forward.

Reputable analysts and brokerage firms issue recommendations upon carrying out extensive research of a company’s operations and performance. The analysis also takes into consideration some of the market conditions that are likely to affect a company in the long run.

By going through such research pages, one can get an insight on where to start when carrying out due diligence on the stocks to invest in. In addition, such reports may provide common investment strategies that one can deploy on a given stock to be able to generate some returns.

Before making an investment decision, it is essential to consider analysts' ratings in addition to other metrics. Analyst’s ratings are never 100% accurate, which means they cannot be taken at face value.  That said, it is important to analyze everything from P/E ratio to earnings per share as well as dividends, risk, and growth of financial strength.

The key to success is analyzing below the surface when it comes to stock analysts' ratings. Never assume that just because a stock is rated a buy, it means it can be bought at any time at any price.

Bottom Line

Analysts’ recommendations in the form of stock ratings are the foundation of equity research reports that should always be used in combination with other personal research work for investment decisions. Buy, sell and hold recommendations should never be put to use without first understanding a firm’s entire scale of ratings.

It is also important for investors to note that analysts and brokerage firms also have agendas. While an analyst's obligation should be to retail shareholders, in reality, that is not always the case.

Some analysts are employed by institutions that own stakes in companies they have already initiated coverage on. Large financial firms, as well as hedge funds and securities, do benefit from certain analyst ratings. When such sums are at stake, it is common for these analysts to issue ratings that are favorable to their holdings, which may not be an accurate reflection of the market conditions.

However, that does not mean that an analyst’s ratings are useless. Analyst's stock research reports do contain vital information. Such information when complemented with other information found by carrying out due diligence could go a long way in helping one make a profitable investment decision.  Stock ratings should always be used as a source of data that complements one's research rather than completes it.

 



MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement
Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.